Clinical Trials
9
Active:0
Completed:7
Trial Phases
2 Phases
Phase 1:2
Phase 2:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (75.0%)Phase 1
2 (25.0%)Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women
Completed
- Conditions
- Menopause
- First Posted Date
- 2013-03-06
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 100
- Registration Number
- NCT01805674
- Locations
- 🇪🇸
Grupo hospitalario Quirón, Erandio, Vizcaya, Spain
🇪🇸Somdex S.L., Barcelona, Spain
🇪🇸Centro Médico Teknon, Barcelona, Spain
Combined Effects of Bioactive Compounds in Lipid Profile
Phase 2
Completed
- Conditions
- HyperlipidemiaLow-density-lipoprotein-typeElevated Triglycerides
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2013-02-28
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 118
- Registration Number
- NCT01562080
- Locations
- 🇪🇸
Hosp. Universitario San Joan, Reus, Tarragona, Spain
Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 19
- Registration Number
- NCT00748787
- Locations
- 🇪🇸
Hospital Universitari San Joan de Reus, Reus, Tarragona, Spain
Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: placebo
- First Posted Date
- 2007-07-27
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 40
- Registration Number
- NCT00507949
- Locations
- 🇪🇸
Neumology Service of the Hospital Universitario Dr. Peset, Valencia, Spain
Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
Phase 1
Completed
- Conditions
- Parkinson's Disease, Idiopathic
- Interventions
- Drug: Plantago ovata huskOther: hemicellulose crystalline
- First Posted Date
- 2007-07-26
- Last Posted Date
- 2007-07-26
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 18
- Registration Number
- NCT00507715
- Locations
- 🇪🇸
Hospital de León, Leon, León, Spain
- Prev
- 1
- 2
- Next
News
No news found